2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$2.29-$0.16 (-6.64%)
Price as of Nov 11, 2026 7:37 PM EST- $140.4MMarket Cap
- -41.13%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$2.29-$0.16 (-6.64%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.46 | ||
Change | -$0.08 (-3.35%) | ||
Open | $2.64 | ||
High | $2.66 | ||
Low | $2.39 | ||
Previous Close | $2.54 | ||
Volume | 3,640,528 | ||
30-Day Average Volume | 1,701,175 | ||
1-Week Change | -42.24% | ||
1-Month Change | -50.30% | ||
1-Year Change | -41.13% | ||
3-Year Change | -39.98% | ||
5-Year Change | -89.52% | ||
Fundamentals | |||
Shares Outstanding | 57.2M | ||
Total Assets | $171.9M | ||
Market Cap | $140.4M | ||
Enterprise Value | $97.8M | ||
Period: QTR TTM FY | |||
Revenue | $2.3M | ||
Net Income | -$5.0M | ||
Free Cash Flow | -$8.5M | ||
EBIT | -$4.4M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $130.0M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 1 | ||
P/E | -31 | ||
PEG | -0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue